nodes	percent_of_prediction	percent_of_DWPC	metapath
Dantrolene—CYP3A4—Calcitriol—psoriasis	0.0965	0.191	CbGbCtD
Dantrolene—CYP3A4—Methoxsalen—psoriasis	0.0751	0.149	CbGbCtD
Dantrolene—CYP3A4—Cholecalciferol—psoriasis	0.0497	0.0986	CbGbCtD
Dantrolene—CYP3A4—Mycophenolate mofetil—psoriasis	0.0431	0.0855	CbGbCtD
Dantrolene—CYP3A4—Triamcinolone—psoriasis	0.0431	0.0855	CbGbCtD
Dantrolene—CYP3A4—Betamethasone—psoriasis	0.037	0.0733	CbGbCtD
Dantrolene—CYP3A4—Prednisolone—psoriasis	0.0365	0.0724	CbGbCtD
Dantrolene—CYP3A4—Hydrocortisone—psoriasis	0.0346	0.0686	CbGbCtD
Dantrolene—CYP3A4—Prednisone—psoriasis	0.0345	0.0683	CbGbCtD
Dantrolene—CYP3A4—Cyclosporine—psoriasis	0.0327	0.0648	CbGbCtD
Dantrolene—CYP3A4—Dexamethasone—psoriasis	0.0215	0.0427	CbGbCtD
Dantrolene—Nausea—Hydroxyurea—psoriasis	0.000361	0.000727	CcSEcCtD
Dantrolene—Pruritus—Mycophenolic acid—psoriasis	0.00036	0.000726	CcSEcCtD
Dantrolene—Myalgia—Triamcinolone—psoriasis	0.000359	0.000724	CcSEcCtD
Dantrolene—Decreased appetite—Cyclosporine—psoriasis	0.000358	0.000721	CcSEcCtD
Dantrolene—Tachycardia—Hydrocortisone—psoriasis	0.000357	0.00072	CcSEcCtD
Dantrolene—Somnolence—Mycophenolate mofetil—psoriasis	0.000357	0.00072	CcSEcCtD
Dantrolene—Drowsiness—Methotrexate—psoriasis	0.000356	0.000719	CcSEcCtD
Dantrolene—Depression—Methotrexate—psoriasis	0.000355	0.000717	CcSEcCtD
Dantrolene—Flushing—Prednisone—psoriasis	0.000355	0.000717	CcSEcCtD
Dantrolene—Ill-defined disorder—Betamethasone—psoriasis	0.000355	0.000716	CcSEcCtD
Dantrolene—Ill-defined disorder—Dexamethasone—psoriasis	0.000355	0.000716	CcSEcCtD
Dantrolene—Discomfort—Triamcinolone—psoriasis	0.000355	0.000716	CcSEcCtD
Dantrolene—Fatigue—Cyclosporine—psoriasis	0.000355	0.000715	CcSEcCtD
Dantrolene—Hyperhidrosis—Hydrocortisone—psoriasis	0.000353	0.000713	CcSEcCtD
Dantrolene—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000353	0.000713	CcSEcCtD
Dantrolene—Pain—Cyclosporine—psoriasis	0.000352	0.00071	CcSEcCtD
Dantrolene—Constipation—Cyclosporine—psoriasis	0.000352	0.00071	CcSEcCtD
Dantrolene—Dry mouth—Triamcinolone—psoriasis	0.000351	0.000708	CcSEcCtD
Dantrolene—Renal failure—Methotrexate—psoriasis	0.00035	0.000707	CcSEcCtD
Dantrolene—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000349	0.000704	CcSEcCtD
Dantrolene—Anorexia—Hydrocortisone—psoriasis	0.000348	0.000703	CcSEcCtD
Dantrolene—Diarrhoea—Mycophenolic acid—psoriasis	0.000348	0.000702	CcSEcCtD
Dantrolene—Malaise—Dexamethasone—psoriasis	0.000345	0.000696	CcSEcCtD
Dantrolene—Malaise—Betamethasone—psoriasis	0.000345	0.000696	CcSEcCtD
Dantrolene—Anaphylactic shock—Triamcinolone—psoriasis	0.000344	0.000694	CcSEcCtD
Dantrolene—Pain—Mycophenolate mofetil—psoriasis	0.000343	0.000692	CcSEcCtD
Dantrolene—Constipation—Mycophenolate mofetil—psoriasis	0.000343	0.000692	CcSEcCtD
Dantrolene—Sweating—Methotrexate—psoriasis	0.000342	0.000689	CcSEcCtD
Dantrolene—Haematuria—Methotrexate—psoriasis	0.00034	0.000686	CcSEcCtD
Dantrolene—Feeling abnormal—Cyclosporine—psoriasis	0.000339	0.000684	CcSEcCtD
Dantrolene—Insomnia—Prednisolone—psoriasis	0.000339	0.000683	CcSEcCtD
Dantrolene—Gastrointestinal pain—Cyclosporine—psoriasis	0.000336	0.000679	CcSEcCtD
Dantrolene—Dizziness—Mycophenolic acid—psoriasis	0.000336	0.000678	CcSEcCtD
Dantrolene—Tachycardia—Triamcinolone—psoriasis	0.000336	0.000678	CcSEcCtD
Dantrolene—Erythema—Prednisone—psoriasis	0.000333	0.000672	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000333	0.000672	CcSEcCtD
Dantrolene—Hyperhidrosis—Triamcinolone—psoriasis	0.000333	0.000671	CcSEcCtD
Dantrolene—Convulsion—Dexamethasone—psoriasis	0.000332	0.000669	CcSEcCtD
Dantrolene—Convulsion—Betamethasone—psoriasis	0.000332	0.000669	CcSEcCtD
Dantrolene—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000331	0.000667	CcSEcCtD
Dantrolene—Insomnia—Hydrocortisone—psoriasis	0.000331	0.000667	CcSEcCtD
Dantrolene—Hypertension—Betamethasone—psoriasis	0.00033	0.000667	CcSEcCtD
Dantrolene—Hypertension—Dexamethasone—psoriasis	0.00033	0.000667	CcSEcCtD
Dantrolene—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000328	0.000662	CcSEcCtD
Dantrolene—Urticaria—Cyclosporine—psoriasis	0.000327	0.000659	CcSEcCtD
Dantrolene—Myalgia—Dexamethasone—psoriasis	0.000326	0.000657	CcSEcCtD
Dantrolene—Myalgia—Betamethasone—psoriasis	0.000326	0.000657	CcSEcCtD
Dantrolene—Abdominal pain—Cyclosporine—psoriasis	0.000325	0.000656	CcSEcCtD
Dantrolene—Body temperature increased—Cyclosporine—psoriasis	0.000325	0.000656	CcSEcCtD
Dantrolene—Vomiting—Mycophenolic acid—psoriasis	0.000323	0.000652	CcSEcCtD
Dantrolene—Discomfort—Betamethasone—psoriasis	0.000322	0.000649	CcSEcCtD
Dantrolene—Discomfort—Dexamethasone—psoriasis	0.000322	0.000649	CcSEcCtD
Dantrolene—Dyspepsia—Hydrocortisone—psoriasis	0.000322	0.000649	CcSEcCtD
Dantrolene—Haemoglobin—Methotrexate—psoriasis	0.000322	0.000649	CcSEcCtD
Dantrolene—Rash—Mycophenolic acid—psoriasis	0.000321	0.000647	CcSEcCtD
Dantrolene—Dermatitis—Mycophenolic acid—psoriasis	0.00032	0.000646	CcSEcCtD
Dantrolene—Pain—Prednisolone—psoriasis	0.00032	0.000646	CcSEcCtD
Dantrolene—Haemorrhage—Methotrexate—psoriasis	0.00032	0.000645	CcSEcCtD
Dantrolene—Hepatitis—Methotrexate—psoriasis	0.00032	0.000645	CcSEcCtD
Dantrolene—Urticaria—Mycophenolate mofetil—psoriasis	0.000319	0.000643	CcSEcCtD
Dantrolene—Headache—Mycophenolic acid—psoriasis	0.000319	0.000643	CcSEcCtD
Dantrolene—Decreased appetite—Hydrocortisone—psoriasis	0.000318	0.000641	CcSEcCtD
Dantrolene—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000317	0.00064	CcSEcCtD
Dantrolene—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000317	0.00064	CcSEcCtD
Dantrolene—Fatigue—Hydrocortisone—psoriasis	0.000315	0.000636	CcSEcCtD
Dantrolene—Vision blurred—Prednisone—psoriasis	0.000314	0.000634	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000314	0.000633	CcSEcCtD
Dantrolene—Pain—Hydrocortisone—psoriasis	0.000313	0.000631	CcSEcCtD
Dantrolene—Anaphylactic shock—Betamethasone—psoriasis	0.000312	0.00063	CcSEcCtD
Dantrolene—Anaphylactic shock—Dexamethasone—psoriasis	0.000312	0.00063	CcSEcCtD
Dantrolene—Insomnia—Triamcinolone—psoriasis	0.000311	0.000628	CcSEcCtD
Dantrolene—Ill-defined disorder—Prednisone—psoriasis	0.000309	0.000624	CcSEcCtD
Dantrolene—Feeling abnormal—Prednisolone—psoriasis	0.000308	0.000622	CcSEcCtD
Dantrolene—Visual impairment—Methotrexate—psoriasis	0.000308	0.000622	CcSEcCtD
Dantrolene—Anaemia—Prednisone—psoriasis	0.000308	0.000621	CcSEcCtD
Dantrolene—Thrombocytopenia—Betamethasone—psoriasis	0.000306	0.000617	CcSEcCtD
Dantrolene—Thrombocytopenia—Dexamethasone—psoriasis	0.000306	0.000617	CcSEcCtD
Dantrolene—Tachycardia—Dexamethasone—psoriasis	0.000305	0.000615	CcSEcCtD
Dantrolene—Tachycardia—Betamethasone—psoriasis	0.000305	0.000615	CcSEcCtD
Dantrolene—Hypersensitivity—Cyclosporine—psoriasis	0.000303	0.000611	CcSEcCtD
Dantrolene—Dyspepsia—Triamcinolone—psoriasis	0.000303	0.000611	CcSEcCtD
Dantrolene—Nausea—Mycophenolic acid—psoriasis	0.000302	0.000609	CcSEcCtD
Dantrolene—Hyperhidrosis—Betamethasone—psoriasis	0.000302	0.000609	CcSEcCtD
Dantrolene—Hyperhidrosis—Dexamethasone—psoriasis	0.000302	0.000609	CcSEcCtD
Dantrolene—Feeling abnormal—Hydrocortisone—psoriasis	0.000301	0.000608	CcSEcCtD
Dantrolene—Malaise—Prednisone—psoriasis	0.000301	0.000606	CcSEcCtD
Dantrolene—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000299	0.000603	CcSEcCtD
Dantrolene—Anorexia—Dexamethasone—psoriasis	0.000298	0.000601	CcSEcCtD
Dantrolene—Anorexia—Betamethasone—psoriasis	0.000298	0.000601	CcSEcCtD
Dantrolene—Urticaria—Prednisolone—psoriasis	0.000297	0.0006	CcSEcCtD
Dantrolene—Fatigue—Triamcinolone—psoriasis	0.000297	0.000599	CcSEcCtD
Dantrolene—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000296	0.000596	CcSEcCtD
Dantrolene—Asthenia—Cyclosporine—psoriasis	0.000295	0.000595	CcSEcCtD
Dantrolene—Pain—Triamcinolone—psoriasis	0.000294	0.000594	CcSEcCtD
Dantrolene—Pruritus—Cyclosporine—psoriasis	0.000291	0.000587	CcSEcCtD
Dantrolene—Urticaria—Hydrocortisone—psoriasis	0.00029	0.000586	CcSEcCtD
Dantrolene—Abdominal pain—Hydrocortisone—psoriasis	0.000289	0.000583	CcSEcCtD
Dantrolene—Body temperature increased—Hydrocortisone—psoriasis	0.000289	0.000583	CcSEcCtD
Dantrolene—Convulsion—Prednisone—psoriasis	0.000289	0.000583	CcSEcCtD
Dantrolene—Asthenia—Mycophenolate mofetil—psoriasis	0.000288	0.000581	CcSEcCtD
Dantrolene—Hypertension—Prednisone—psoriasis	0.000288	0.00058	CcSEcCtD
Dantrolene—Chills—Methotrexate—psoriasis	0.000287	0.000579	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000285	0.000574	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000285	0.000574	CcSEcCtD
Dantrolene—Pruritus—Mycophenolate mofetil—psoriasis	0.000284	0.000573	CcSEcCtD
Dantrolene—Myalgia—Prednisone—psoriasis	0.000284	0.000572	CcSEcCtD
Dantrolene—Feeling abnormal—Triamcinolone—psoriasis	0.000284	0.000572	CcSEcCtD
Dantrolene—Insomnia—Betamethasone—psoriasis	0.000283	0.00057	CcSEcCtD
Dantrolene—Insomnia—Dexamethasone—psoriasis	0.000283	0.00057	CcSEcCtD
Dantrolene—Diarrhoea—Cyclosporine—psoriasis	0.000281	0.000568	CcSEcCtD
Dantrolene—Discomfort—Prednisone—psoriasis	0.00028	0.000566	CcSEcCtD
Dantrolene—Erythema—Methotrexate—psoriasis	0.000279	0.000562	CcSEcCtD
Dantrolene—Hypersensitivity—Prednisolone—psoriasis	0.000276	0.000556	CcSEcCtD
Dantrolene—Dyspepsia—Dexamethasone—psoriasis	0.000275	0.000555	CcSEcCtD
Dantrolene—Dyspepsia—Betamethasone—psoriasis	0.000275	0.000555	CcSEcCtD
Dantrolene—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000275	0.000554	CcSEcCtD
Dantrolene—Urticaria—Triamcinolone—psoriasis	0.000273	0.000552	CcSEcCtD
Dantrolene—Dysgeusia—Methotrexate—psoriasis	0.000273	0.00055	CcSEcCtD
Dantrolene—Body temperature increased—Triamcinolone—psoriasis	0.000272	0.000549	CcSEcCtD
Dantrolene—Dizziness—Cyclosporine—psoriasis	0.000272	0.000549	CcSEcCtD
Dantrolene—Anaphylactic shock—Prednisone—psoriasis	0.000272	0.000549	CcSEcCtD
Dantrolene—Decreased appetite—Betamethasone—psoriasis	0.000272	0.000548	CcSEcCtD
Dantrolene—Decreased appetite—Dexamethasone—psoriasis	0.000272	0.000548	CcSEcCtD
Dantrolene—Back pain—Methotrexate—psoriasis	0.000269	0.000544	CcSEcCtD
Dantrolene—Hypersensitivity—Hydrocortisone—psoriasis	0.000269	0.000543	CcSEcCtD
Dantrolene—Fatigue—Dexamethasone—psoriasis	0.000269	0.000543	CcSEcCtD
Dantrolene—Fatigue—Betamethasone—psoriasis	0.000269	0.000543	CcSEcCtD
Dantrolene—Pain—Betamethasone—psoriasis	0.000267	0.000539	CcSEcCtD
Dantrolene—Pain—Dexamethasone—psoriasis	0.000267	0.000539	CcSEcCtD
Dantrolene—Tachycardia—Prednisone—psoriasis	0.000265	0.000536	CcSEcCtD
Dantrolene—Dizziness—Mycophenolate mofetil—psoriasis	0.000265	0.000535	CcSEcCtD
Dantrolene—Hyperhidrosis—Prednisone—psoriasis	0.000263	0.00053	CcSEcCtD
Dantrolene—Vision blurred—Methotrexate—psoriasis	0.000263	0.00053	CcSEcCtD
Dantrolene—Asthenia—Hydrocortisone—psoriasis	0.000262	0.000529	CcSEcCtD
Dantrolene—Vomiting—Cyclosporine—psoriasis	0.000262	0.000528	CcSEcCtD
Dantrolene—Rash—Cyclosporine—psoriasis	0.000259	0.000523	CcSEcCtD
Dantrolene—Anorexia—Prednisone—psoriasis	0.000259	0.000523	CcSEcCtD
Dantrolene—Dermatitis—Cyclosporine—psoriasis	0.000259	0.000523	CcSEcCtD
Dantrolene—Pruritus—Hydrocortisone—psoriasis	0.000259	0.000522	CcSEcCtD
Dantrolene—Ill-defined disorder—Methotrexate—psoriasis	0.000258	0.000521	CcSEcCtD
Dantrolene—Headache—Cyclosporine—psoriasis	0.000258	0.00052	CcSEcCtD
Dantrolene—Anaemia—Methotrexate—psoriasis	0.000257	0.000519	CcSEcCtD
Dantrolene—Feeling abnormal—Dexamethasone—psoriasis	0.000257	0.000519	CcSEcCtD
Dantrolene—Feeling abnormal—Betamethasone—psoriasis	0.000257	0.000519	CcSEcCtD
Dantrolene—Gastrointestinal pain—Dexamethasone—psoriasis	0.000255	0.000515	CcSEcCtD
Dantrolene—Gastrointestinal pain—Betamethasone—psoriasis	0.000255	0.000515	CcSEcCtD
Dantrolene—Vomiting—Mycophenolate mofetil—psoriasis	0.000255	0.000515	CcSEcCtD
Dantrolene—Hypersensitivity—Triamcinolone—psoriasis	0.000254	0.000512	CcSEcCtD
Dantrolene—Rash—Mycophenolate mofetil—psoriasis	0.000253	0.00051	CcSEcCtD
Dantrolene—Dermatitis—Mycophenolate mofetil—psoriasis	0.000253	0.00051	CcSEcCtD
Dantrolene—Headache—Mycophenolate mofetil—psoriasis	0.000251	0.000507	CcSEcCtD
Dantrolene—Malaise—Methotrexate—psoriasis	0.000251	0.000507	CcSEcCtD
Dantrolene—Diarrhoea—Hydrocortisone—psoriasis	0.00025	0.000505	CcSEcCtD
Dantrolene—Leukopenia—Methotrexate—psoriasis	0.000249	0.000503	CcSEcCtD
Dantrolene—Urticaria—Dexamethasone—psoriasis	0.000248	0.000501	CcSEcCtD
Dantrolene—Urticaria—Betamethasone—psoriasis	0.000248	0.000501	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Prednisone—psoriasis	0.000248	0.0005	CcSEcCtD
Dantrolene—Dizziness—Prednisolone—psoriasis	0.000248	0.000499	CcSEcCtD
Dantrolene—Asthenia—Triamcinolone—psoriasis	0.000247	0.000498	CcSEcCtD
Dantrolene—Body temperature increased—Dexamethasone—psoriasis	0.000247	0.000498	CcSEcCtD
Dantrolene—Abdominal pain—Betamethasone—psoriasis	0.000247	0.000498	CcSEcCtD
Dantrolene—Abdominal pain—Dexamethasone—psoriasis	0.000247	0.000498	CcSEcCtD
Dantrolene—Body temperature increased—Betamethasone—psoriasis	0.000247	0.000498	CcSEcCtD
Dantrolene—Insomnia—Prednisone—psoriasis	0.000246	0.000496	CcSEcCtD
Dantrolene—Nausea—Cyclosporine—psoriasis	0.000244	0.000493	CcSEcCtD
Dantrolene—Pruritus—Triamcinolone—psoriasis	0.000244	0.000491	CcSEcCtD
Dantrolene—Dizziness—Hydrocortisone—psoriasis	0.000242	0.000488	CcSEcCtD
Dantrolene—Convulsion—Methotrexate—psoriasis	0.000241	0.000487	CcSEcCtD
Dantrolene—Dyspepsia—Prednisone—psoriasis	0.000239	0.000483	CcSEcCtD
Dantrolene—Nausea—Mycophenolate mofetil—psoriasis	0.000238	0.000481	CcSEcCtD
Dantrolene—Myalgia—Methotrexate—psoriasis	0.000237	0.000478	CcSEcCtD
Dantrolene—Decreased appetite—Prednisone—psoriasis	0.000236	0.000477	CcSEcCtD
Dantrolene—Rash—Prednisolone—psoriasis	0.000236	0.000476	CcSEcCtD
Dantrolene—Dermatitis—Prednisolone—psoriasis	0.000236	0.000476	CcSEcCtD
Dantrolene—Fatigue—Prednisone—psoriasis	0.000235	0.000473	CcSEcCtD
Dantrolene—Headache—Prednisolone—psoriasis	0.000235	0.000473	CcSEcCtD
Dantrolene—Discomfort—Methotrexate—psoriasis	0.000234	0.000473	CcSEcCtD
Dantrolene—Constipation—Prednisone—psoriasis	0.000233	0.000469	CcSEcCtD
Dantrolene—Vomiting—Hydrocortisone—psoriasis	0.000232	0.000469	CcSEcCtD
Dantrolene—Rash—Hydrocortisone—psoriasis	0.000231	0.000465	CcSEcCtD
Dantrolene—Dermatitis—Hydrocortisone—psoriasis	0.00023	0.000465	CcSEcCtD
Dantrolene—Confusional state—Methotrexate—psoriasis	0.000229	0.000462	CcSEcCtD
Dantrolene—Headache—Hydrocortisone—psoriasis	0.000229	0.000462	CcSEcCtD
Dantrolene—Dizziness—Triamcinolone—psoriasis	0.000228	0.000459	CcSEcCtD
Dantrolene—Anaphylactic shock—Methotrexate—psoriasis	0.000227	0.000459	CcSEcCtD
Dantrolene—Feeling abnormal—Prednisone—psoriasis	0.000224	0.000452	CcSEcCtD
Dantrolene—Asthenia—Dexamethasone—psoriasis	0.000224	0.000452	CcSEcCtD
Dantrolene—Asthenia—Betamethasone—psoriasis	0.000224	0.000452	CcSEcCtD
Dantrolene—Thrombocytopenia—Methotrexate—psoriasis	0.000223	0.000449	CcSEcCtD
Dantrolene—Gastrointestinal pain—Prednisone—psoriasis	0.000222	0.000449	CcSEcCtD
Dantrolene—Nausea—Prednisolone—psoriasis	0.000222	0.000449	CcSEcCtD
Dantrolene—Pruritus—Dexamethasone—psoriasis	0.000221	0.000446	CcSEcCtD
Dantrolene—Pruritus—Betamethasone—psoriasis	0.000221	0.000446	CcSEcCtD
Dantrolene—Hyperhidrosis—Methotrexate—psoriasis	0.00022	0.000443	CcSEcCtD
Dantrolene—Vomiting—Triamcinolone—psoriasis	0.000219	0.000442	CcSEcCtD
Dantrolene—Nausea—Hydrocortisone—psoriasis	0.000217	0.000438	CcSEcCtD
Dantrolene—Rash—Triamcinolone—psoriasis	0.000217	0.000438	CcSEcCtD
Dantrolene—Dermatitis—Triamcinolone—psoriasis	0.000217	0.000437	CcSEcCtD
Dantrolene—Anorexia—Methotrexate—psoriasis	0.000217	0.000437	CcSEcCtD
Dantrolene—Urticaria—Prednisone—psoriasis	0.000216	0.000436	CcSEcCtD
Dantrolene—Headache—Triamcinolone—psoriasis	0.000216	0.000435	CcSEcCtD
Dantrolene—Body temperature increased—Prednisone—psoriasis	0.000215	0.000434	CcSEcCtD
Dantrolene—Abdominal pain—Prednisone—psoriasis	0.000215	0.000434	CcSEcCtD
Dantrolene—Diarrhoea—Dexamethasone—psoriasis	0.000214	0.000431	CcSEcCtD
Dantrolene—Diarrhoea—Betamethasone—psoriasis	0.000214	0.000431	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000207	0.000418	CcSEcCtD
Dantrolene—Dizziness—Dexamethasone—psoriasis	0.000207	0.000417	CcSEcCtD
Dantrolene—Dizziness—Betamethasone—psoriasis	0.000207	0.000417	CcSEcCtD
Dantrolene—Insomnia—Methotrexate—psoriasis	0.000206	0.000415	CcSEcCtD
Dantrolene—Nausea—Triamcinolone—psoriasis	0.000204	0.000412	CcSEcCtD
Dantrolene—Somnolence—Methotrexate—psoriasis	0.000202	0.000408	CcSEcCtD
Dantrolene—Hypersensitivity—Prednisone—psoriasis	0.0002	0.000404	CcSEcCtD
Dantrolene—Dyspepsia—Methotrexate—psoriasis	0.0002	0.000404	CcSEcCtD
Dantrolene—Vomiting—Betamethasone—psoriasis	0.000199	0.000401	CcSEcCtD
Dantrolene—Vomiting—Dexamethasone—psoriasis	0.000199	0.000401	CcSEcCtD
Dantrolene—Decreased appetite—Methotrexate—psoriasis	0.000198	0.000399	CcSEcCtD
Dantrolene—Rash—Dexamethasone—psoriasis	0.000197	0.000397	CcSEcCtD
Dantrolene—Rash—Betamethasone—psoriasis	0.000197	0.000397	CcSEcCtD
Dantrolene—Dermatitis—Betamethasone—psoriasis	0.000197	0.000397	CcSEcCtD
Dantrolene—Dermatitis—Dexamethasone—psoriasis	0.000197	0.000397	CcSEcCtD
Dantrolene—Fatigue—Methotrexate—psoriasis	0.000196	0.000395	CcSEcCtD
Dantrolene—Headache—Dexamethasone—psoriasis	0.000196	0.000395	CcSEcCtD
Dantrolene—Headache—Betamethasone—psoriasis	0.000196	0.000395	CcSEcCtD
Dantrolene—Asthenia—Prednisone—psoriasis	0.000195	0.000394	CcSEcCtD
Dantrolene—Pain—Methotrexate—psoriasis	0.000194	0.000392	CcSEcCtD
Dantrolene—Pruritus—Prednisone—psoriasis	0.000192	0.000388	CcSEcCtD
Dantrolene—Feeling abnormal—Methotrexate—psoriasis	0.000187	0.000378	CcSEcCtD
Dantrolene—Diarrhoea—Prednisone—psoriasis	0.000186	0.000375	CcSEcCtD
Dantrolene—Gastrointestinal pain—Methotrexate—psoriasis	0.000186	0.000375	CcSEcCtD
Dantrolene—Nausea—Betamethasone—psoriasis	0.000186	0.000374	CcSEcCtD
Dantrolene—Nausea—Dexamethasone—psoriasis	0.000186	0.000374	CcSEcCtD
Dantrolene—Urticaria—Methotrexate—psoriasis	0.000181	0.000364	CcSEcCtD
Dantrolene—Dizziness—Prednisone—psoriasis	0.00018	0.000363	CcSEcCtD
Dantrolene—Body temperature increased—Methotrexate—psoriasis	0.00018	0.000363	CcSEcCtD
Dantrolene—Abdominal pain—Methotrexate—psoriasis	0.00018	0.000363	CcSEcCtD
Dantrolene—Vomiting—Prednisone—psoriasis	0.000173	0.000349	CcSEcCtD
Dantrolene—Rash—Prednisone—psoriasis	0.000172	0.000346	CcSEcCtD
Dantrolene—Dermatitis—Prednisone—psoriasis	0.000171	0.000346	CcSEcCtD
Dantrolene—Headache—Prednisone—psoriasis	0.00017	0.000344	CcSEcCtD
Dantrolene—Hypersensitivity—Methotrexate—psoriasis	0.000167	0.000338	CcSEcCtD
Dantrolene—Asthenia—Methotrexate—psoriasis	0.000163	0.000329	CcSEcCtD
Dantrolene—Nausea—Prednisone—psoriasis	0.000162	0.000326	CcSEcCtD
Dantrolene—Pruritus—Methotrexate—psoriasis	0.000161	0.000324	CcSEcCtD
Dantrolene—Diarrhoea—Methotrexate—psoriasis	0.000156	0.000314	CcSEcCtD
Dantrolene—Dizziness—Methotrexate—psoriasis	0.00015	0.000303	CcSEcCtD
Dantrolene—Vomiting—Methotrexate—psoriasis	0.000145	0.000292	CcSEcCtD
Dantrolene—Rash—Methotrexate—psoriasis	0.000143	0.000289	CcSEcCtD
Dantrolene—Dermatitis—Methotrexate—psoriasis	0.000143	0.000289	CcSEcCtD
Dantrolene—Headache—Methotrexate—psoriasis	0.000142	0.000287	CcSEcCtD
Dantrolene—Nausea—Methotrexate—psoriasis	0.000135	0.000272	CcSEcCtD
